Abstract
BackgroundGuillain-Barre syndrome (GBS) reffers to acute inflammatory demyelinating polyneuropathy for which two different treatments methods show equal efficacy: plasmapheresis and high dose of immunoglobulins. Cost minimisation analysis compares expenses of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Hospital Pharmacy: Science and Practice
Paper Title
Journal
Date
